亿胜生物科技有限公司（股票代码：01061）于2026年6月24日发布翌日披露报表，宣布在当日回购普通股247,000股，占该公告披露前已发行股份总数（不包括库藏股）约0.04359%。本次回购价格区间为每股2.61港元至2.64港元，累计耗资约64.87万港元。
回购完成后，公司已发行股份总数（不包括库藏股）为566,433,000股，库藏股总数增至573,000股。根据此前于2026年5月26日通过的购回授权，亿胜生物科技可回购股份的总数为56,700,600股。截至此次回购，公司已回购573,000股，占购回授权通过当日公司已发行股份总数约0.10106%。
公告同时确认，公司已遵守香港联合交易所有限公司证券上市规则及相关法律规章。本公告由公司董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.